Fundación Instituto para la Mejora de la Asistencia Sanitaria, Madrid, Spain.
Fundación Instituto para la Mejora de la Asistencia Sanitaria, Madrid, Spain; Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, Spain.
Rev Clin Esp (Barc). 2021 Aug-Sep;221(7):400-403. doi: 10.1016/j.rceng.2020.11.006. Epub 2021 May 19.
To analyze the association between public health expenditure per capita and the mortality rate due to COVID-19 in Europe and Spain.
Pearson's correlation coefficient was used to compare and contrast the mortality rate due to COVID-19 between countries and autonomous communities with higher and lower public health expenditure per capita than the mean.
No correlation between the public health expenditure per capita and the mortality rate due to COVID-19 (r: 0.3; p = 0.14) was found among European countries or Spain's Autonomous Communities (r: 0.03; p = 0.91). No significant differences were found when comparing the mortality rate due to COVID-19 among the public health expenditure per capita groups.
The available evidence does not support association between «low» public healthcare expenditure and the poor outcomes observed in Spain during the COVID-19 pandemic. Increased funding for the Spanish National Health System should be earmarked for structural reforms to increase its social efficiency.
分析欧洲和西班牙人均公共卫生支出与 COVID-19 死亡率之间的关系。
采用 Pearson 相关系数比较和对比人均公共卫生支出高于或低于平均值的国家和自治区之间 COVID-19 死亡率。
在欧洲国家或西班牙自治区之间，未发现人均公共卫生支出与 COVID-19 死亡率之间存在相关性（r：0.3；p=0.14）。当比较人均公共卫生支出组之间 COVID-19 死亡率时，未发现显著差异。
现有证据不支持“低”公共卫生支出与西班牙在 COVID-19 大流行期间观察到的不良结果之间存在关联。应将增加西班牙国家卫生系统的资金用于结构性改革，以提高其社会效率。
